Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals, Inc. is listed in the United States. Sector: Healthcare. Industry: Biotechnology.

Alnylam Pharmaceuticals, Inc. (ALNY): research close 156.50 USD on 2026-11-17. 52-week range 151.64 to 473.29 USD. Historical research data, not advice.

Dated company evidence

FactFigureAs of
Historical research close156.50 USD2026-11-17
Previous research close159.73 USD2026-11-16
Change between the two dated research closes-2.02%2026-11-16 – 2026-11-17
Market capitalisation21.37 billion USD2026-11-16
52-week range of the research close151.64 – 473.29 USD2025-11-18 – 2026-11-17
One-year change in the research close-66.02%2025-11-17 – 2026-11-17
Average daily turnover (20 sessions)582.81 million USD2026-11-17

Source: us_closes_adjusted · US · research close

Historical research prices; adjustments vary by market. This is not a live quote or a forecast.

Continue your company research

Members can compare available company evidence and explicitly save ALNY to a watchlist. A company is saved only after Save is pressed for it.

Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.

Nine member offerings. Free. No card.

Join free

Research, not advice.

Research on this page's measures

Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate

Most-traded US companies

Full list of most-traded US companies